Speech in Public Bill Committees - Wed 14 Apr 2021
Advanced Research and Invention Agency Bill (Second sitting)
"Great—thank you. Dr Dugan, I saw you nodding as well.
Dr Dugan: If we want to get down to some specifics, I think it is important to recognise that the evaluation process for us is very much about separating the abstracts or the proposals into two baskets: those that are …..."Dawn Butler - View Speech
View all Dawn Butler (Lab - Brent East) contributions to the debate on: Advanced Research and Invention Agency Bill (Second sitting)
Speech in Public Bill Committees - Wed 14 Apr 2021
Advanced Research and Invention Agency Bill (Second sitting)
"Q My final question is to you all. How important do you think the link should be between ARIA and UKRI in the UK? Perhaps we will start with Professor Azoulay, because you have read the Bill very carefully.
Professor Azoulay: I think that those two modes of funding …..."Dawn Butler - View Speech
View all Dawn Butler (Lab - Brent East) contributions to the debate on: Advanced Research and Invention Agency Bill (Second sitting)
Speech in Public Bill Committees - Wed 14 Apr 2021
Advanced Research and Invention Agency Bill (Second sitting)
"Thank you. Dr Dugan?
Dr Dugan: Pierre makes a very good point. These are important elements of a robust and functioning ecosystem. We talked about the advances in mRNA, which have been so important in the corona pandemic. That relied on basic science, curiosity-driven research that happened mostly through NIH, …..."Dawn Butler - View Speech
View all Dawn Butler (Lab - Brent East) contributions to the debate on: Advanced Research and Invention Agency Bill (Second sitting)
Speech in Public Bill Committees - Wed 14 Apr 2021
Advanced Research and Invention Agency Bill (Second sitting)
"Thank you. Dr Highnam?
Dr Highnam: I am afraid that I do not know enough about your structures to be able to give a sensible answer...."Dawn Butler - View Speech
View all Dawn Butler (Lab - Brent East) contributions to the debate on: Advanced Research and Invention Agency Bill (Second sitting)
Speech in Public Bill Committees - Wed 14 Apr 2021
Advanced Research and Invention Agency Bill (Second sitting)
"No problem. Thank you very much...."Dawn Butler - View Speech
View all Dawn Butler (Lab - Brent East) contributions to the debate on: Advanced Research and Invention Agency Bill (Second sitting)
Speech in Public Bill Committees - Wed 14 Apr 2021
Advanced Research and Invention Agency Bill (First sitting)
"Q Dame Ottoline, you said earlier that you expect a close working relationship with ARIA. What does that actually look like? Legislatively, what should that look like?
Professor Leyser: It is an interesting question as to the extent to which that needs to be written into legislation. In my …..."Dawn Butler - View Speech
View all Dawn Butler (Lab - Brent East) contributions to the debate on: Advanced Research and Invention Agency Bill (First sitting)
Speech in Public Bill Committees - Wed 14 Apr 2021
Advanced Research and Invention Agency Bill (First sitting)
"I agree with you that there needs to be a close working relationship. I do not think we can count on it happening naturally. I have two quick questions, if I may, Ms McVey?..."Dawn Butler - View Speech
View all Dawn Butler (Lab - Brent East) contributions to the debate on: Advanced Research and Invention Agency Bill (First sitting)
Speech in Public Bill Committees - Wed 14 Apr 2021
Advanced Research and Invention Agency Bill (First sitting)
"Q It was a quick one on why UKRI cannot access the innovators of tomorrow—the people coding at home. I did not understand what was stopping UKRI doing that?
Professor Leyser: At the moment, most of our funding opportunities require people to apply for a research grant. People coding …..."Dawn Butler - View Speech
View all Dawn Butler (Lab - Brent East) contributions to the debate on: Advanced Research and Invention Agency Bill (First sitting)
Written Question
Tuesday 1st December 2020
Asked by:
Dawn Butler (Labour - Brent East)
Question
to the Department for Business, Energy and Industrial Strategy:
To ask the Secretary of State for Business, Energy and Industrial Strategy, whether any of the covid-19 vaccines purchased by the Government for use in the UK have been tested on people with sickle cell and thalassemia blood disorders.
Answered by Amanda Solloway
We expect safety data from all trials to set out how the COVID-19 vaccines work in different types of people.
The NHS COVID-19 vaccine research registry, developed in partnership with NHS Digital, will help facilitate the rapid recruitment of large numbers of people into trials. The government has been encouraging a diverse pool of people to volunteer to help researchers better understand the effectiveness of each vaccine candidate
Specific questions on individual vaccines are for vaccine developers.
Written Question
Thursday 9th July 2020
Asked by:
Dawn Butler (Labour - Brent East)
Question
to the Department for Business, Energy and Industrial Strategy:
To ask the Secretary of State for Business, Energy and Industrial Strategy, what discussions officials of his Department have had with representatives from employer organisations on recent changes in advice to clinically extremely vulnerable people who are shielding with (a) arthritis and (b) other conditions.
Answered by Paul Scully
Officials regularly meet with representatives from employer bodies and discussions have included recent changes in the advice to the Clinically Extremely Vulnerable.
More generally, BEIS leads for Government on the Safer Working Guidance. This sets out the steps employers can take to ensure that the workplace is secure for everyone. This guidance is updated as necessary following changes in public health advice. Individuals and organisations, including those with interest in specific conditions such as arthritis, are able to comment on the guidance through safer.workplaces@beis.gov.uk.